Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. 5 years ago Research & Clinical Trial Webinars,Webinars You may also like 58:48 Webinar: Transforming the Treatment Paradigm with Dyne Therapeutics (March 31, 2021) 5 years ago Research & Clinical Trial Webinars,Webinars 56:15 Webinar: Santhera Pharmaceuticals Duchenne Drug Development Update (March 24, 2021) 5 years ago Research & Clinical Trial Webinars,Webinars 1:10:10 Webinar: Solid Biosciences Presents Safety & Efficacy Update (March 16, 2021) 5 years ago Research & Clinical Trial Webinars,Webinars 42:08 Assessing the Risk of Arrhythmias and Sudden Cardiac Events in Duchenne (March 4, 2021) 5 years ago Research & Clinical Trial Webinars,Webinars 50:55 Weekend Steroids and Exercise for Duchenne (March 3, 2021) 5 years ago Research & Clinical Trial Webinars,Webinars 42:48 Family Friday: Independent Living (January 29, 2021) 5 years ago Family Friday,For Teens & Adults,Webinars 1:01:12 Planning For Your Future: Navigating Benefits & Finances (January 28, 2021) 5 years ago Care Webinars,Webinars 43:57 PPMD’s Biomarkers Initiative 5 years ago Research & Clinical Trial Webinars,Webinars «1…910111213…28»Page 11 of 28